63629-4093 Ondansetron Hydrochloride

Product NDC:

63629-4093

Brand Name:

Ondansetron Hydrochloride

Generic Name:

Ondansetron Hydrochloride

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: Ondansetron Hydrochloride

Strength: 8.0

Unit: mg/1

Packages:

Code: 63629-4093-00

Description: 5 TABLET, FILM COATED in 1 BOTTLE (63629-4093-0)

Effective Date: April 27, 2010

Discontinued:

Code: 63629-4093-01

Description: 10 TABLET, FILM COATED in 1 BOTTLE (63629-4093-1)

Effective Date: June 3, 2009

Discontinued:

Code: 63629-4093-02

Description: 15 TABLET, FILM COATED in 1 BOTTLE (63629-4093-2)

Effective Date: June 3, 2009

Discontinued:

Code: 63629-4093-03

Description: 4 TABLET, FILM COATED in 1 BOTTLE (63629-4093-3)

Effective Date: June 3, 2009

Discontinued:

Code: 63629-4093-04

Description: 3 TABLET, FILM COATED in 1 BOTTLE (63629-4093-4)

Effective Date: June 3, 2009

Discontinued:

Code: 63629-4093-05

Description: 12 TABLET, FILM COATED in 1 BOTTLE (63629-4093-5)

Effective Date: June 3, 2009

Discontinued:

Code: 63629-4093-06

Description: 20 TABLET, FILM COATED in 1 BOTTLE (63629-4093-6)

Effective Date: June 3, 2009

Discontinued:

Code: 63629-4093-07

Description: 30 TABLET, FILM COATED in 1 BOTTLE (63629-4093-7)

Effective Date: April 27, 2010

Discontinued:

Code: 63629-4093-08

Description: 60 TABLET, FILM COATED in 1 BOTTLE (63629-4093-8)

Effective Date: April 27, 2010

Discontinued:

Code: 63629-4093-09

Description: 6 TABLET, FILM COATED in 1 BOTTLE (63629-4093-9)

Effective Date: April 27, 2010

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC